Exercise therapy to prevent and treat Alzheimer's disease

被引:32
|
作者
Pahlavani, Hamed Alizadeh [1 ]
机构
[1] Farhangian Univ, Dept Phys Educ, Tehran, Iran
来源
关键词
exercise; Alzheimer's disease; aerobic training; anaerobic training; strength training; PHYSICAL-EXERCISE; NEUROTROPHIC FACTOR; AEROBIC EXERCISE; COGNITIVE FUNCTION; OXIDATIVE STRESS; HORMONE IRISIN; KETOGENIC DIET; MOUSE MODEL; HIPPOCAMPUS; NEUROINFLAMMATION;
D O I
10.3389/fnagi.2023.1243869
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disease in the elderly with dementia, memory loss, and severe cognitive impairment that imposes high medical costs on individuals. The causes of AD include increased deposition of amyloid beta (A & beta;) and phosphorylated tau, age, mitochondrial defects, increased neuroinflammation, decreased synaptic connections, and decreased nerve growth factors (NGF). While in animals moderate-intensity exercise restores hippocampal and amygdala memory through increased levels of p-AKT, p-TrkB, and p-PKC and decreased levels of A & beta;, tau phosphorylation, and amyloid precursor proteins (APP) in AD. Aerobic exercise (with an intensity of 50-75% of VO2 max) prevents hippocampal volume reduction, spatial memory reduction, and learning reduction through increasing synaptic flexibility. Exercise training induces the binding of brain-derived neurotrophic factor (BDNF) to TrkB and the binding of NGF to TrkA to induce cell survival and neuronal plasticity. After aerobic training and high-intensity interval training, the increase of VEGF, angiopoietin 1 and 2, NO, tPA, and HCAR1 in cerebral vessels causes increased blood flow and angiogenesis in the cerebellum, motor cortex, striatum, and hippocampus. In the hippocampus, exercise training decreases mitochondrial fragmentation, DRP1, and FIS1, improving OPA1, MFN1, MFN2, and mitochondrial morphology. In humans, acute exercise as an anti-inflammatory condition causes an acute increase in IL-6 and an increase in anti-inflammatory factors such as IL-1RA and IL-10. Moderate-intensity exercise also inhibits inflammatory markers such as IFN-& gamma;, IL-1 & beta;, IL-6, CRP, TNF-& alpha;, sTNFR1, COX-2, and NF-& kappa;B. Aerobic exercise significantly increases plasma levels of BDNF, nerve growth factor, synaptic plasticity, motor activity, spatial memory, and exploratory behavior in AD subjects. Irisin is a myokine released from skeletal muscle during exercise and protects the hippocampus by suppressing A & beta; accumulation and promoting hippocampal proliferation through STAT3 signaling. Therefore, combined exercise training such as aerobic training, strength training, balance and coordination training, and cognitive and social activities seems to provide important benefits for people with AD.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Does Lithium Prevent Alzheimer's Disease?
    Forlenza, Orestes V.
    de Paula, Vanessa J.
    Machado-Vieira, Rodrigo
    Diniz, Breno S.
    Gattaz, Wagner F.
    DRUGS & AGING, 2012, 29 (05) : 335 - 342
  • [42] Collaborative efforts to prevent Alzheimer's disease
    Touchon, J.
    Rosenbaum, J.
    Aisen, P.
    Andrieu, S.
    Carrillo, M. C.
    Ceccaldi, M.
    Dartiques, J. -F.
    Feldman, H.
    Gabelle, A.
    Isaac, M.
    Fitten, L. J.
    Sperling, R. A.
    Vellas, B.
    Tariot, P.
    Weiner, M.
    JOURNAL OF NUTRITION HEALTH & AGING, 2017, 21 (10): : 1072 - 1074
  • [43] Exercise to prevent and treat functional disability
    Singh, MAF
    CLINICS IN GERIATRIC MEDICINE, 2002, 18 (03) : 431 - +
  • [44] Exercise to prevent and treat diabetes mellitus
    Beamer, BA
    PHYSICIAN AND SPORTSMEDICINE, 2000, 28 (10): : 85 - 86
  • [45] Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
    Carrillo, Maria C.
    Brashear, H. Robert
    Logovinsky, Veronika
    Ryan, J. Michael
    Feldman, Howard H.
    Siemers, Eric R.
    Abushakra, Susan
    Hartley, Dean M.
    Petersen, Ronald C.
    Khachaturian, Ara S.
    Sperling, Reisa A.
    ALZHEIMERS & DEMENTIA, 2013, 9 (02) : 123 - 131
  • [46] Alzheimer's disease: facing the biological complexity to treat the disease
    Govoni, S
    PHARMACOLOGICAL RESEARCH, 2004, 50 (04) : 381 - 383
  • [47] LET'S TREAT ALZHEIMER'S DISEASE GENETIC ASPECTS
    Frisoni, G. B.
    Tagliavini, F.
    Sorbi, S.
    Padovani, A.
    Scarpini, E.
    Babiloni, C.
    Pievani, M.
    Bruni, Amalia C.
    NEUROBIOLOGY OF AGING, 2012, 33 : S4 - S5
  • [48] Silencing tau to treat early Alzheimer’s disease
    Peter A. Ljubenkov
    Gil D. Rabinovici
    Nature Medicine, 2023, 29 : 1320 - 1321
  • [49] Could antivirals be used to treat Alzheimer's disease?
    Itzhaki, Ruth F.
    Wozniak, Matthew A.
    FUTURE MICROBIOLOGY, 2012, 7 (03) : 307 - 309
  • [50] Can We Treat Neuroinflammation in Alzheimer's Disease?
    Sanchez-Sarasua, Sandra
    Fernandez-Perez, Ivan
    Espinosa-Fernandez, Veronica
    Maria Sanchez-Perez, Ana
    Carlos Ledesma, Juan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 23